<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Wall St. Cheat Sheet &#187; Coach Remains Compelling and 4 Stock Analyses to Follow</title>
	<atom:link href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/feed/" rel="self" type="application/rss+xml" />
	<link>http://wallstcheatsheet.com</link>
	<description>Financial Media for Trading, Investing, and Business</description>
	<lastBuildDate>Sat, 18 May 2013 17:01:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Coach Remains Compelling and 4 Stock Analyses to Follow</title>
		<link>http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/</link>
		<comments>http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/#comments</comments>
		<pubDate>Thu, 24 Jan 2013 17:18:58 +0000</pubDate>
		<dc:creator>Leah Powell</dc:creator>
				<category><![CDATA[Business]]></category>
		<category><![CDATA[coach]]></category>
		<category><![CDATA[Investing]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Trading]]></category>
<stock_tickers>
<ticker><![CDATA[NASDAQ:DNKN]]></ticker>
<ticker><![CDATA[NASDAQ:ESRX]]></ticker>
<ticker><![CDATA[NYSE:AH]]></ticker>
<ticker><![CDATA[NYSE:BSX]]></ticker>
<ticker><![CDATA[NYSE:COH]]></ticker>
</stock_tickers>
		<guid isPermaLink="false">http://wallstcheatsheet.com/?p=372582</guid>
		<description><![CDATA[Here's what analysts had to say about these companies today...]]></description>
				<content:encoded><![CDATA[<p><strong>Accretive Health, Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=AH" target="_blank">NYSE:AH</a>): Current Price: $13.11</p>
<p>Accretive Health has been added to the Focus List at Raymond James (pre-open).</p>
<p><a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/attachment/picture-158/" rel="attachment wp-att-372624"><img class="alignnone size-full wp-image-372624" alt="Picture 158" src="http://images.wallstcheatsheet.com/wp-content/uploads/2013/01/Picture-158-e1359046313519.png" width="625" height="250" /></a></p>
<div class="text-ad" style="border: 1px solid #999; padding: 10px 15px; font-size: 12px; font-style: italic; margin-bottom: 15px;"><em>Markets are at 5-year highs! Discover the best stocks to own. <a href="https://wallstcheatsheet.com/newsletters/wscs-premium/?ref=PBAL">Click here for our fresh Feature Stock Pick now</a>!</em></div>
<p><!--nextpage--></p>
<p><img title="Next page..." alt="" src="http://wscseditor.wpengine.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" /></p>
<p><strong>Express Scripts Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=ESRX" target="_blank">NASDAQ:ESRX</a>): Current Price: $53.70</p>
<p>UBS has defended shares of Express Scripts.</p>
<p><a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/attachment/picture-159/" rel="attachment wp-att-372626"><img class="alignnone size-full wp-image-372626" alt="Picture 159" src="http://images.wallstcheatsheet.com/wp-content/uploads/2013/01/Picture-159-e1359046349275.png" width="625" height="249" /></a></p>
<p><!--nextpage--></p>
<p><img title="Next page..." alt="" src="http://wscseditor.wpengine.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" /></p>
<p><strong>Dunkin&#8217; Brands Group Inc</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=DNKN" target="_blank">NASDAQ:DNKN</a>): Current Price: $36.24</p>
<p>The company&#8217;s target has been raised by Argus due to the company&#8217;s intentions for unit expansion. The firm believes that Dunkin&#8217; Brands has significant growth opportunities, and it keeps its Buy rating on the stock.</p>
<p><a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/attachment/picture-160/" rel="attachment wp-att-372629"><img class="alignnone size-full wp-image-372629" alt="Picture 160" src="http://images.wallstcheatsheet.com/wp-content/uploads/2013/01/Picture-160-e1359046388866.png" width="625" height="250" /></a></p>
<p><!--nextpage--></p>
<p><img title="Next page..." alt="" src="http://wscseditor.wpengine.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" /></p>
<p><strong>Coach Inc.</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=COH" target="_blank">NYSE:COH</a>): Current Price: $51.33</p>
<p>According to Barclays, Coach&#8217;s brand continues to be strong and its shares remain compelling currently. The firm gives the stock an Overweight rating and a $65 price target, down from $75.</p>
<p><a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/attachment/picture-161/" rel="attachment wp-att-372634"><img class="alignnone size-full wp-image-372634" alt="Picture 161" src="http://images.wallstcheatsheet.com/wp-content/uploads/2013/01/Picture-1611-e1359046429355.png" width="625" height="249" /></a></p>
<p><!--nextpage--></p>
<p><img title="Next page..." alt="" src="http://wscseditor.wpengine.com/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif" /></p>
<p><strong>Boston Scientific Corporation</strong> (<a href="http://wallstcheatsheet.com/stock-research/company?qs=BSX" target="_blank">NYSE:BSX</a>): Current Price: $6.78</p>
<p>According to Goldman, nothing has changed for Boston Scientific after its recent share strength, and Goldman keeps its Sell rating on the stock. The analyst stated that no evidence exists that is able to support a shift towards implantable cardioverter defibrillators, drug eluting stents are still facing volume and price headwinds, growth outlook is flat, and pipeline products are too small to drive growth near-term. The firm gives the stock a price target of 5.20.</p>
<p><a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/attachment/picture-162/" rel="attachment wp-att-372636"><img class="alignnone size-full wp-image-372636" alt="Picture 162" src="http://images.wallstcheatsheet.com/wp-content/uploads/2013/01/Picture-1621-e1359046457395.png" width="625" height="252" /></a></p>
<p><strong>Don&#8217;t Miss</strong>: <a href="http://wallstcheatsheet.com/stocks/should-caterpillar-have-noticed-this-red-flag.html/" target="_blank">Should Caterpillar Have Noticed This Red Flag?</a></p>
<p><em> </em></p>
 Read the <a href="http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/">original article</a> from Wall St. Cheat Sheet]]></content:encoded>
			<wfw:commentRss>http://wallstcheatsheet.com/stocks/coach-remains-compelling-and-4-stock-analyses-to-follow.html/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

